Plasma and urine biomarkers in acute viral hepatitis E

Proteome Science

Volumn 7, Issue , 2009, Pages

  Taneja, Shikha ^a   Sen, Somdutta ^b   Gupta, Vijay K ^c   Aggarwal, Rakesh ^d   Jameel, Shahid ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b Centre for Genomic Application   (India)

^c ARMY HOSPITAL   (India)

^d SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ACID GLYCOPROTEIN PRECURSOR 1; ALPHA 1 ACID GLYCOPROTEIN PRECURSOR 2; ALPHA 1 MICROGLOBULIN; AMYLOID P PRECURSOR PROTEIN; APOLIPOPROTEIN A1; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; CYSTATIN C; FETUIN A; FIBRINOGEN; FIBRINOGEN GAMMA A CHAIN PRECURSOR; FIBRINOGEN GAMMA B CHAIN PRECURSOR; HAPTOGLOBIN; HEMOPEXIN; INTERLEUKIN 6 SIGNAL TRANSDUCER ISOFORM 1 PRECURSOR; LIPOCALIN; LIPOCORTIN 2; MEMBRANE ASSOCIATED GUANYLATE KINASE 2; N2B TITIN ISOFORM; PREALBUMIN; PROSTAGLANDIN D2 SYNTHASE; PROTEIN ODF2; RASGAP ACTIVATING LIKE PROTEIN 1; RETINOL BINDING PROTEIN; TAU TUBULIN KINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VITAMIN D BINDING PROTEIN; ZINC ALPHA 2 GLYCOPROTEIN CHAIN A;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEPATITIS E; HUMAN; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS;

HEPATITIS E VIRUS;

EID: 71149093697     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-7-39     Document Type: Article

References (45)

1. Purcell RH, Emerson SU. Hepatitis E Virus. Fields Virology 2001, 3051-3062. Philadelphia: Lippincott Williams and Wilkins, Knipe DM, Howley PM.
2. International Committee for Taxonomy of Viruses; 2009 proposals. , http://talk.ictvonline.org/media/p/1194.aspx
3. Matsuda H, Okada K, Takahashi K, Mishiro S. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect Dis 2003, 188:944. 10.1086/378074, 12964128.
4. Tei S, Kitajima N, Ohara S, Inoue Y, Miki M, Yamatani T, Yamabe H, Mishiro S, Kinoshita Y. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age- and sex-matched case-control study. J Med Virol 2004, 74:67-70. 10.1002/jmv.20147, 15258970.
5. Zheng Y, Ge S, Zhang J, Guo Q, Ng MH, Wang F, Xia N, Jiang Q. Swine as a principal reservoir of hepatitis E virus that infects humans in eastern China. J Infect Dis 2006, 193:1643-1649. 10.1086/504293, 16703507.
6. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, Rech H, Destruel F, Izopet J. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008, 80:289-293. 10.1002/jmv.21056, 18098159.
7. Panda SK, Jameel S. Hepatitis E virus: from epidemiology to molecular biology. Vir Hep Rev 1997, 3:227-51.
8. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981, 70:252-255. 10.1016/0002-9343(81)90758-0, 6781338.
9. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007, 147:28-33.
10. Borman S. Proteomics: Taking over where genomics leaves off. Chemical & Engineering News 2000, 78:31-7.
11. Conrads TP, Hood BL, Petricoin EF, Liotta LA, Veenstra TD. Cancer proteomics: many technologies, one goal. Expert Rev Proteomics 2005, 2:693-703. 10.1586/14789450.2.5.693, 16209649.
12. Petricoin E, Wulfkuhle J, Espina V, Liotta LA. Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. J Proteome Res 2004, 3:209-217. 10.1021/pr049972m, 15113096.
13. Patton WF. Detection technologies in proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2002, 771:3-31. 10.1016/S1570-0232(02)00043-0, 12015990.
14. Zhou G, Li H, DeCamp D, Chen S, Shu H, Gong Y, Flaig M, Gillespie JW, Hu N, Taylor PR. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 2002, 1:117-124. 10.1074/mcp.M100015-MCP200, 12096129.
15. Hammer O, Harper DAT, Ryan PD. PAST: Palaeontological Statistics software package for education and data analysis. Palaeontologia Electronica 2001, 4(1):9.
16. Hoagland L, Campa MJ, Gottlin EB, Herndon JE, Patz EF. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer. Cancer 2007, 110:2260-2268. 10.1002/cncr.23049, 17918261.
17. Ang IL, Poon TC, Lai PB, Chan AT, Ngai SM, Hui AY, Johnson PJ, Sung JJ. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J Proteome Res 2006, 5:2691-2700. 10.1021/pr060109r, 17022640.
18. Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, Niederle B, Dudczak R, Pirich C. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 2004, 89:515-519. 10.1210/jc.2003-030709, 14764755.
19. Triantafillidis JK, Tzourmakliotis D, Peros G, Merikas E, Barbatzas C, Cheracakis P, Gikas A, Konstandellou E. Serum gastrin levels in patients with inflammatory bowel disease. Hepatogastroenterology 2003, 50(Suppl 2):cccxv-cccxvii.
20. Yokota H, Hiramoto M, Okada H, Kanno Y, Yuri M, Morita S, Naitou M, Ichikawa A, Katoh M, Suzuki H. Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria. Mol Cell Proteomics 2007, 6:738-744. 10.1074/mcp.M600336-MCP200, 17242005.
21. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 1992, 89:373-377. 48239, 1309612, 10.1073/pnas.89.1.373.
22. Otegbayo JA, Arinola OG, Aje A, Oluwasola OA, Okiwelu OH, Salimonu LS. Usefulness of acute phase proteins for monitoring development of hepatocellular carcinoma in hepatitis B virus carriers. West Afr J Med 2005, 24:124-127.
23. Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Chen DS, Yu CY, Wen CL, Lu FJ, Chow LP. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics 2006, 6:2865-2873. 10.1002/pmic.200500488, 16586433.
24. Gangadharan B, Antrobus R, Dwek RA, Zitzmann N. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem 2007, 53:1792-1799. 10.1373/clinchem.2007.089144, 17702858.
25. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454. 10.1056/NEJM199902113400607, 9971870.
26. Tolosano E, Fagoonee S, Hirsch E, Berger FG, Baumann H, Silengo L, Altruda F. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood 2002, 100:4201-4208. 10.1182/blood-2002-04-1270, 12393471.
27. Tolosano E, Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol 2002, 21:297-306. 10.1089/104454902753759717, 12042069.
28. Fournier T, Medjoubi NN, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta 2000, 1482:157-171.
29. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA 1998, 95:14429-14434. 24390, 9826717, 10.1073/pnas.95.24.14429.
30. Chandra V, Kar-Roy A, Kumari S, Mayor S, Jameel S. The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J Virol 2008, 82:7100-7110. 2446974, 18448545, 10.1128/JVI.00403-08.
31. Yasmin MY, Aziz B, Nazim M, Madhavan RK. Prealbumin rather than albumin is a more sensitive indicator of acute liver disease. Malays J Pathol 1993, 15:147-150.
32. Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics 2006, 5:1760-71. 10.1074/mcp.R600004-MCP200, 16837576.
33. Sala A, Campagnoli M, Perani E, Romano A, Labo S, Monzani E, Minchiotti L, Galliano M. Human alpha-1-microglobulin is covalently bound to kynurenine-derived chromophores. J Biol Chem 2004, 279:51033-51041. 10.1074/jbc.M408242200, 15452109.
34. Olsson MG, Allhorn M, Olofsson T, Akerstrom B. Up-regulation of alpha1-microglobulin by hemoglobin and reactive oxygen species in hepatoma and blood cell lines. Free Radic Biol Med 2007, 42:842-851. 10.1016/j.freeradbiomed.2006.12.017, 17320766.
35. Berggard T, Oury TD, Thogersen IB, Akerstrom B, Enghild JJ. Alpha1-microglobulin is found both in blood and in most tissues. J Histochem Cytochem 1998, 46:887-894.
36. Falkenberg C, Blom A, Fries E, Ekstrom G, Sarnstrand B, Salier JP, Akerstrom B. Alpha1-microglobulin and bikunin in rats with collagen II-induced arthritis: plasma levels and liver mRNA content. Scand J Immunol 1997, 46:122-128. 10.1046/j.1365-3083.1997.d01-103.x, 9583992.
37. Yu H, Yanagisawa Y, Forbes MA, Cooper EH, Crockson RA, MacLennan IC. Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol 1983, 36:253-259. 498194, 6186698, 10.1136/jcp.36.3.253.
38. Tyagi S, Surjit M, Roy AK, Jameel S, Lal SK. The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte. J Biol Chem 2004, 279:29308-29319. 10.1074/jbc.M402017200, 15037615.
39. Nagoshi H, Uehara Y, Kanai F, Maeda S, Ogura T, Goto A, Toyo-oka T, Esumi H, Shimizu T, Omata M. Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ Res 1998, 82:204-209.
40. Hoffmann A, Nimtz M, Conradt HS. Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases. Glycobiology 1997, 7:499-506. 10.1093/glycob/7.4.499, 9184830.
41. Melegos DN, Grass L, Pierratos A, Diamandis EP. Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 1999, 53:32-37. 10.1016/S0090-4295(98)00453-1, 9886584.
42. Burgi W, Schmid K. Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. J Biol Chem 1961, 236:1066-1074.
43. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 1998, 58:2359-2365.
44. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S, Tisdale MJ, Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 2004, 101:2500-2505. 356979, 14983038, 10.1073/pnas.0308647100.
45. Rolli V, Radosavljevic M, Astier V, Macquin C, Castan-Laurell I, Visentin V, Guigne C, Carpene C, Valet P, Gilfillan S, Bahram S. Lipolysis is altered in MHC class I zinc-alpha(2)-glycoprotein deficient mice. FEBS Lett 2007, 581:394-400. 10.1016/j.febslet.2006.12.047, 17234189.